KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Other financing activities (2016 - 2025)

Elevance Health (ELV) has disclosed Other financing activities for 15 consecutive years, with $21.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Other financing activities rose 2000.0% to $21.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.0 million, a 72.73% decrease, with the full-year FY2024 number at $2.0 million, down 71.43% from a year prior.
  • Other financing activities was $21.0 million for Q3 2025 at Elevance Health, up from $3.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $171.0 million in Q1 2021 to a low of -$357.0 million in Q4 2021.
  • A 5-year average of -$16.1 million and a median of $3.0 million in 2023 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: plummeted 450.0% in 2024, then skyrocketed 2000.0% in 2025.
  • Elevance Health's Other financing activities stood at -$357.0 million in 2021, then soared by 107.0% to $25.0 million in 2022, then plummeted by 92.0% to $2.0 million in 2023, then tumbled by 450.0% to -$7.0 million in 2024, then soared by 400.0% to $21.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELV's Other financing activities are $21.0 million (Q3 2025), $3.0 million (Q2 2025), and -$14.0 million (Q1 2025).